A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Umkamin Tab in Acute Bronchitis Patients
Status:
Completed
Trial end date:
2018-09-21
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blinded, Active-controlled, Parallel, Phase III Clinical
Trial to Evaluate the Efficacy and Safety of HL301 versus Umkamin tab. in acute bronchitis
patients
Endpoint: BSS, The improvement and improvement rate of the tester for the treatment response,
The satisfaction of the subject